| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/06/2008 | CN100366240C Ultraviolet-shielding type patch |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326697 Methods for increasing the therapeutic response to electroconvulsive therapy |
| 02/05/2008 | US7326690 Buffer intracellular reduction and oxidation for the stressed cells in various disease states; beneficial as adjunctive support therapy, multiple chemical sensitivity syndrome, Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Roussy-Levy syndrome, Rosenberg Chutorian syndrome, Korsakoff syndrome |
| 02/05/2008 | US7326541 Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof |
| 02/05/2008 | US7326427 Tablet composition containing Kampo medicinal extract and its manufacturing process |
| 02/05/2008 | US7326425 Biologically active compound hydrogen bonded to a first polyester containing tyrosine-derived diphenol units blended with a second polymer that degrades to promote the release of the active compound |
| 02/05/2008 | US7326421 Device and methods for sequential, regional delivery of multiple cytotoxic agents and directed assembly of wound repair tissues |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326174 Cardiac disease treatment and device |
| 02/05/2008 | US7325355 Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 02/05/2008 | CA2278140C Administration of products of the 5-lipoxygenase metabolic pathway to enhance antimicrobial defense |
| 01/31/2008 | WO2008014478A2 Nanocell drug delivery system |
| 01/31/2008 | WO2008014401A2 Methods for identifying modulators of rgs21 activity, compositions comprising an rgs21 modulator, and methods of use thereof to modulate taste sensation |
| 01/31/2008 | WO2008014338A2 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 01/31/2008 | WO2008014299A2 Use of an alpha2-agonist composition for the treatment of hyperlipidemia |
| 01/31/2008 | WO2008013270A1 Method for diagnosis of neuropsychiatric disease |
| 01/31/2008 | WO2008012932A1 Insulin resistance reducer |
| 01/31/2008 | WO2008012290A2 Quinuclidine derivatives as m3 antagonists |
| 01/31/2008 | WO2008011799A1 NEW USE OF NON-RECEPTOR TYROSINE KINASE c-Ab1 SPECIFIC INHIBITORS |
| 01/31/2008 | WO2008011726A1 Staged immune-response modulation in oncolytic therapy |
| 01/31/2008 | WO2008011713A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | WO2008011672A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027148 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies |
| 01/31/2008 | US20080027146 Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases |
| 01/31/2008 | US20080027140 Combinations of Serotonin Reuptake Inhibitors and Imidazoline I 2 Agonists |
| 01/31/2008 | US20080027133 Use of chromen-4-one derivatives |
| 01/31/2008 | US20080027123 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating erythema nodosum leprosum in leprosy, rhematoid spondylitis, hepatitis or congestive heart failure |
| 01/31/2008 | US20080027032 Combinations comprising cox-2 inhibitors and aspirin |
| 01/31/2008 | US20080027023 Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives |
| 01/31/2008 | US20080027022 Method to treat gastric lesions |
| 01/31/2008 | US20080026987 Use of Liver-Selective Glucokinase Activators |
| 01/31/2008 | US20080026426 Anti-infective therapy |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026399 treating bladder and lower urinary tract syndromes particularly irrative symptoms using alpha 1d-adrenergic receptor ( alpha 1dAR) antagonists; drug screening |
| 01/31/2008 | US20080026371 Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject Outcome |
| 01/31/2008 | US20080026086 Synergistic Neuroprotective, Combinations Of Flavanols, Hydroxystilbenes, Flavanones, Flavones, Flavonols, Proanthocyanidins And Anthocyanidins |
| 01/31/2008 | US20080026081 Methods of Treatment Using (+)-Isopropyl 2-Ethoxyethyl-4-(2-Chloro-3-Cyano-Phenyl)-1,4-Dihydro-2,6-Dimethyl-Pyridine-3,5-Dicarboxylate |
| 01/31/2008 | US20080026076 Quercetin supplementation to treat hypertension |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026045 Combination Chemotherapy Comprising a Gemcitabine and a Liposomal Platium Complex |
| 01/31/2008 | US20080026044 Combination Chemotherapy Comprising Capecitabine and a Liposomal Platinum Complex |
| 01/31/2008 | US20080026037 Compositions Comprising Strontium and Vitamin D and Uses Thereof |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026003 Methods for inhibiting pain |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025992 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| 01/31/2008 | US20080025983 Methods of screening based on the EGF receptor crystal structure |
| 01/31/2008 | US20080025967 Method and Kit for Detecting Proliferative Diseases Causing Sclerosis, Preventive and/or Remedy for Proliferative Diseases Causing Sclerosis and Method and Kit for Identifying Substance Efficacious in Preventing and/or Treating Proliferative Diseases Causing Sclerosis |
| 01/31/2008 | US20080025913 Novel Anti-Dc-Sign Antibodies |
| 01/31/2008 | CA2694428A1 Compositions and methods for treatment of advanced prostate cancer |
| 01/31/2008 | CA2659012A1 Methods of diagnosis and treatment for metabolic disorders |
| 01/31/2008 | CA2658649A1 Quinuclidine derivatives as m3 antagonists |
| 01/31/2008 | CA2658584A1 Staged immune-response modulation in oncolytic therapy |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1882691A1 Quinuclidine derivatives as M3 antagonists |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882480A2 High glycerin containing anti-microbial cleansers |
| 01/30/2008 | EP1882041A2 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof |
| 01/30/2008 | EP1881835A1 Triazine compounds and compositions thereof for the treatment of cancers |
| 01/30/2008 | EP1881833A1 Compositions for the treatment of psoriasis |
| 01/30/2008 | EP1881832A2 Use of flibanserin in the treatment of chronic pain |
| 01/30/2008 | EP1881824A1 Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
| 01/30/2008 | EP1881821A2 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures |
| 01/30/2008 | EP1468110A4 Molecular signatures of commonly fatal carcinomas |
| 01/30/2008 | EP1280420B1 Natural vegetable oil concentrated in unsaponifiable matters as food ingredient |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | CN101115506A Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 01/30/2008 | CN101115505A Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
| 01/30/2008 | CN101115483A Pharmaceutical composition containing fbpase-inhibiting agent |
| 01/30/2008 | CN101115467A Analgesic compositions |
| 01/30/2008 | CN100365120C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/30/2008 | CN100364532C Composition containing amlodipine and angiotensin II receptor inhibitor |
| 01/30/2008 | CN100364498C Oral aerosol for reducing or eliminating snore and its preparation method |
| 01/29/2008 | US7323543 Insulin, insulin-related peptide, and sensitizer; side effect reduction |
| 01/29/2008 | US7323491 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 01/29/2008 | US7323479 Immunomodulators; side effect reduction |
| 01/29/2008 | US7323463 Combination of brimonidine and timolol for topical ophthalmic use |
| 01/29/2008 | US7323461 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | US7323453 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 01/29/2008 | US7323449 1-(2-(Hydroxymethyl)-5-thiolanyl)pyrrolo[2.3d]pyrimidine derivatives or their phosphates: 4-amino-7-(2-C-methyl-4-thio- beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine; hepatitis C virus |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323173 Administration of phosphorylated Mammastatin having a molecular weight of 53 kDa or 49 kDa; the polypeptide is specifically reactive with monoclonal antibody 7G6 that is produced from hybridoma ATCC No. HB10152 |
| 01/29/2008 | US7323168 Immunotherapy for chronic myelocytic leukemia |
| 01/29/2008 | US7323166 Lactic acid bacteria cultures that inhibit food-borne pathogens |
| 01/29/2008 | US7323164 Can be administered in conjunction with radiation or chemotherapeutic agents. |
| 01/29/2008 | CA2505930C Use of botulinum toxin in the preparation of a pharmaceutical composition for treating urinary retention |
| 01/29/2008 | CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 01/29/2008 | CA2417607C Lipase inhibitors for the treatment of dyspepsia |
| 01/29/2008 | CA2417455C Novel cyclooxygenase variants and methods of use |
| 01/29/2008 | CA2406367C Method for treating pain by peripheral administration of a neurotoxin |
| 01/29/2008 | CA2323458C Metal chelators for use in the treatment of alzheimer's disease |